Globe Life Inc. (NYSE:GL) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Globe Life Inc. (NYSE:GL) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $171.3333.

GL has been the topic of several recent research reports. Evercore set a $157.00 price objective on Globe Life in a report on Wednesday, February 18th. JPMorgan Chase & Co. upped their target price on Globe Life from $180.00 to $181.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Weiss Ratings upgraded Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th. Wells Fargo & Company lifted their price target on Globe Life from $170.00 to $171.00 and gave the company an “overweight” rating in a research note on Wednesday, February 25th. Finally, TD Cowen restated a “buy” rating on shares of Globe Life in a report on Thursday, December 11th.

Insider Activity

In other Globe Life news, CEO James Matthew Darden sold 18,318 shares of the company’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total value of $2,657,941.80. Following the completion of the transaction, the chief executive officer directly owned 51,093 shares in the company, valued at approximately $7,413,594.30. This represents a 26.39% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CMO Jennifer Allison Haworth sold 10,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $143.14, for a total transaction of $1,431,400.00. Following the transaction, the chief marketing officer directly owned 17,479 shares of the company’s stock, valued at $2,501,944.06. The trade was a 36.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 92,186 shares of company stock worth $13,358,379. Company insiders own 1.51% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after acquiring an additional 607 shares during the last quarter. NewEdge Advisors LLC increased its position in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares during the period. Goldman Sachs Group Inc. raised its holdings in Globe Life by 11.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after purchasing an additional 58,163 shares during the last quarter. Empowered Funds LLC bought a new position in Globe Life during the 1st quarter worth approximately $428,000. Finally, Focus Partners Wealth lifted its position in shares of Globe Life by 8.3% in the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after purchasing an additional 656 shares during the period. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Price Performance

Shares of NYSE:GL opened at $142.41 on Friday. Globe Life has a one year low of $109.38 and a one year high of $152.71. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market cap of $11.20 billion, a price-to-earnings ratio of 10.11 and a beta of 0.46. The firm has a 50 day simple moving average of $142.04 and a 200 day simple moving average of $138.98.

Globe Life (NYSE:GL) last posted its earnings results on Wednesday, February 4th. The company reported $3.39 earnings per share for the quarter, missing analysts’ consensus estimates of $3.44 by ($0.05). The company had revenue of $1.52 billion for the quarter, compared to the consensus estimate of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $3.14 EPS. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Research analysts predict that Globe Life will post 13.87 earnings per share for the current fiscal year.

Globe Life Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Friday, April 3rd will be given a dividend of $0.33 per share. The ex-dividend date is Thursday, April 2nd. This represents a $1.32 annualized dividend and a yield of 0.9%. This is a boost from Globe Life’s previous quarterly dividend of $0.27. Globe Life’s dividend payout ratio is 7.67%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.